Article
Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice.
British journal of pharmacology - 1 Mar 1999
Zhu Q M, Lesnick J D, Jasper J R, MacLennan S J, Dillon M P, Eglen R M, Blue D R
Abstract excerpt
1. We investigated the cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor mice. The in vitro pharmacology of these agonists was determined at recombinant (human) alpha2-adrenoceptors and at endogenous (dog) alpha2A-adrenoceptors. 2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
